Ashraf Malhas, PhD

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.

Articles by Ashraf Malhas, PhD

News

Approval of Sickle Cell Disease Bill by Senate Committee Welcomed by Emmaus Life Sciences

A U.S. Senate committee unanimously supported the Sickle Cell Disease Act of 2018, and Emmaus Life Sciences is also announcing its…

News

Increasing Doses of Hydroxyurea Benefits Young Sickle Cell Patients

Researchers have found that a new dosing regimen of the drug hydroxyurea results in levels of fetal hemoglobin above 20 percent…

Subscribe to our newsletter

Get regular updates to your inbox.